Mobile Menu - OpenMobile Menu - Closed

Hearing on "Examining FDA’s Prescription Drug User Fee Program," Subcommittee on Health (March 22, 2017)

Wednesday, March 22, 2017 - 10:15am
2322 Rayburn House Office Building

The Subcommittee on Health will hold a hearing on Wednesday, March 22, 2017, at 10:15 a.m. in 2322 Rayburn House Office Building.  The hearing is entitled “Examining FDA’s Prescription Drug User Fee Program.”  




Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health

Opening Statement of Subcommittee Ranking Member Green as prepared for delivery



Panel I

Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Panel II

Anne Pritchett
Vice President, Policy and Research
Kay Holcombe
Senior Vice President of Science Policy
Biotechnology Industry Organization
Jeff Allen
President & CEO
Friends of Cancer Research